iiinova — where your digital self keeps evolving

Reposted by Blood Journals Portfolio

American Society of Hematology @ash.hematology.org · 09/10/2026

Happy #HispanicHeritageMonth from ASH! 🎉 ASH celebrates the remarkable contributions of Hispanic and Latino/a/x hematologists, researchers, and clinicians advancing research and care for people with blood disorders. 🩸 #HemeSky #MedSky

051 5

Reposted by Blood Journals Portfolio

American Society of Hematology @ash.hematology.org · 02/09/2026

Advances in the treatment of major blood cancers have saved more than 25 million years of life in the United States over the past 75 years. But gains have not reached everyone equally. Read more from Blood Cancer United new in Blood Journal ow.ly/H1iv50ZIgiH

121 2

Blood Journals Portfolio @bloodjournals.hematology.org · 09/09/2026

New issue of Blood Global Hematology out now featuring Inequities in clinical trial availability in Europe, The correlation between Hb and the clinical spectrum of SCA, Rethinking Hispanic/Latino as an ethnic category in leukemia research and more. Explore here: ashpublications.org/bloodglobal/...

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 03/09/2026

New issue of Blood out now featuring The hidden role of neutrophils in steroid-resistant GVHD, IL-16 drives a novel pathway of BTK inhibitor resistance, Precision transfusion medicine in the omics era and more. Explore here: ashpublications.org/blood/issue/...

000 0

Reposted by Blood Journals Portfolio

Ajay Major, MD, MBA @majorajay.bsky.social · 01/09/2026

Proud to share our @ash.hematology.org @bloodjournals.hematology.org, led by my trainee Dr. @vpizzuti.bsky.social @cuinternalmed.bsky.social. Longitudinal PROs and QoL trajectories over 2 years after CAR T-cell therapy. #lymsm #mmsm🧵 doi.org/10.1016/j.bn...

162 6

Blood Journals Portfolio @bloodjournals.hematology.org · 31/08/2026

New issue of Blood Neoplasia is out featuring Co-option of lineage plasticity as a hallmark of multipotent acute leukemias, Autologous transplant for patients with chemotherapy-sensitive late relapse of diffuse large B-cell lymphoma and more. Explore here: ashpublications.org/bloodneoplas...

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 27/08/2026

New issue of Blood VTH out now! Featuring New insights into flavonoid binding to the thromboxane A2 receptor, Sirolimus outperforms alpelisib in models of NRASQ61R-driven vascular overgrowth, and more. Explore here: ashpublications.org/bloodvth/iss...

000 0

Reposted by Blood Journals Portfolio

Yale School of Medicine @yaleschoolofmed.bsky.social · 24/08/2026

Writing in Blood Advances, Layla Van Doren, MD, and colleagues report increased #burnout among #physicians focused on #SickleCell disease (SCD) compared to their non-SCD-focused peers. medicine.yale.edu/publication-... @bloodjournals.hematology.org

Layla Van Doren, MD, speaks with a colleague at Yale New Haven Hospital.

011 1

Reposted by Blood Journals Portfolio

Axel Künstner @knstnr.bsky.social · 14/08/2026

New in Blood @bloodjournals.hematology.org lenalidomide (maintenance tx in myeloma) raises B-ALL risk. We show WHY in a subset of cases IDH2 R140Q clonal hematopoiesis + lenalidomide-driven IKAROS loss cooperate to arrest B-cell dev., seeding a distinct leukemia subtype. 🧵 doi.org/10.1182/bloo...

doi.org

IDH2 clonal hematopoiesis and IKAROS loss cooperate in a B-ALL subtype after lenalidomide therapy for multiple myeloma

Key PointsIDH2 R140Q mutations define a distinct B-ALL subtype that is highly enriched in LenB-ALL.IDH2mt LenB-ALL emerges from IDH2-mutant clonal hematopo

121 2

Blood Journals Portfolio @bloodjournals.hematology.org · 13/08/2026

🎙️ Just published a new episode of Blood Podcast: Cost-Effectiveness of Current SCD Treatments and Potential Therapeutic Targets for Fetal Hemoglobinopathies. Have a listen:

bloodpodcast.transistor.fm

Cost-Effectiveness of Current SCD Treatments and Potential Therapeutic Targets for Fetal Hemoglobinopathies

In this week's episode, Blood editor Dr. James Griffin interviews Drs....

000 0

Reposted by Blood Journals Portfolio

American Society of Hematology @ash.hematology.org · 07/08/2026

After more than 30 years of extraordinary leadership, Martha "Marty" Liggett, Esq., will retire as ASH Executive Director. The Society has named Matthew Gertzog, FASAE, MBA, as its next Chief Executive Officer, effective January 1, 2027. Learn more: ow.ly/XRag50ZxEhX #HemeSky

032 3

Blood Journals Portfolio @bloodjournals.hematology.org · 06/08/2026

New issue of Blood out now featuring Discovery and preclinical activity of ziftomenib, Single-day nonactivated IL-18 CAR T-cell therapy, RAASi and anemia in SCD, and more. Explore here: ashpublications.org/blood/issue/...

010 1

Reposted by Blood Journals Portfolio

Ajay Major, MD, MBA @majorajay.bsky.social · 04/08/2026

Congratulations to my mentee Dr. @vpizzuti.bsky.social on this analysis of 2 years of PRO data in CAR-T recipients, now published @bloodjournals.hematology.org. CAR-T confers long-term QoL benefits, and worsening patient-reported fatigue at D+15 may predict subsequent response as a "PRO-marker."

232 3

Reposted by Blood Journals Portfolio

American Society of Hematology @ash.hematology.org · 27/07/2026

This Thursday, join the ASH Journal Club webinar to explore how integrated omics data, mouse models, and CRISPR screening are advancing research in NPM1-mutant AML. Enroll now: ow.ly/7RQS50ZtnWa #HemeSky

031 3

Blood Journals Portfolio @bloodjournals.hematology.org · 30/07/2026

New issue of Blood out now featuring Epigenetic toggling between multipotency and differentiation, Nanotube trafficking fuels myeloma bone loss, Promises and potential pitfalls of in vivo CAR gene therapy, and more. Explore here: ashpublications.org/blood/issue/...

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 23/07/2026

New issue of Blood out now featuring ASH HematOmics Program, Clinical spectrum of hereditary hemorrhagic telangiectasia, RNF217 modulates iron metabolism, and more. Explore here: ashpublications.org/blood/issue/...

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 16/07/2026

New issue of Blood out now featuring OutFOXing a FENDRR bender in T-ALL, Crossing the trial-practice chasm in CAR-T for relapsed LBCL, Oxidized PDI promotes thrombus formation, and more. Explore here: ashpublications.org/blood/issue/...

030 3

Blood Journals Portfolio @bloodjournals.hematology.org · 10/07/2026

New issue of Blood out now featuring MDM4-related bone marrow failure, Pavurutamab in relapsed myeloma, Phenotype-driven analysis of PIEZO1 variants, and more. Explore here: ashpublications.org/blood/issue/...

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 01/07/2026

We're thrilled to welcome a new Associate Editor to Blood today! Dr. Omar Abdel-Wahab is the Evnin Family Chair of Molecular Pharmacology at @mskcancercenter.bsky.social where he also serves as Chair of the Molecular Pharmacology Program in the Sloan Kettering Institute. #NewEditor

042 4

Blood Journals Portfolio @bloodjournals.hematology.org · 25/06/2026

New issue of Blood out now featuring Freeze-dried platelets for traumatic brain injury, Clonal evolution of NPM1-mutated AML, Iron overload rewires HSC metabolism, and more. Explore here: ashpublications.org/blood/issue/...

020 2

Blood Journals Portfolio @bloodjournals.hematology.org · 23/06/2026

New issue of Blood Advances out now featuring Eligibility versus appropriateness in allogeneic HCT, Targeting erythroid cell–derived asparagine inhibits alloimmunization in sickle cell disease, Remission with residuals, but no cure and more. Explore here: ashpublications.org/bloodadvance...

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 23/06/2026

Congratulations to Dr. Andrew Roberts, Editor-in-Chief of Blood, for being awarded the Helen M. Ranney Clinical and Translational Science Medal and Dr. Stella Chou, Blood Editorial Board Member, for earning the William Dameshek Prize.

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 22/06/2026

New issue of Blood RCI out now featuring Red blood cells as sensors of stress in ultramarathons, Emerging concepts in sickle cell disease acute chest syndrome, Iron-refractory iron deficiency anemia and more. Explore here: ashpublications.org/bloodrci/iss...

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 18/06/2026

New issue of Blood out now! Featuring Immune-mediated side effects of cancer immunotherapies, The prevalence and clinical significance of clonal monocytosis, and more. Explore here: ashpublications.org/blood/issue/...

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 17/06/2026

We're proud to share that Blood has a JIF of 23.9 and continues its position as the most-cited journal in hematology, with 168,805 total citations in 2025. Blood Advances' JIF is 7.7. With 26,750 citations in 2025, it's among the top ten most cited hematology journals. #JCR2026

030 3

Blood Journals Portfolio @bloodjournals.hematology.org · 11/06/2026

New issue of Blood out now featuring Ven-aza and the bone marrow niche, Complement activation in ITP, CD7 CAR T cells for relapsed/refractory AML, and more. Explore here: ashpublications.org/blood/issue/...

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 10/06/2026

New issue of Blood Global Hematology out now! Featuring Developing nations’ guide to Hodgkin lymphoma, The challenge of treating African children with hydroxyurea, Sickle cell disease: then and now, and more. Explore here: ashpublications.org/bloodglobal/...

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 09/06/2026

New issue of Blood Advances out now featuring Real-world experience with tabelecleucel, Management of relapsed/refractory AL amyloidosis, and more. Explore here: ashpublications.org/bloodadvance...

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 04/06/2026

New issue of Blood out now featuring Predictive markers of glofitamab resistance, CREBBP mutations and lymphomagensis, Arterial thrombosis in hypofibrinogenemia and more. Explore here: ashpublications.org/blood/issue/...

011 1